The global defibrillators market size is estimated to be USD 12.01 billion in 2021 and is expected to witness a CAGR of 9.97% during the forecast period. Growth focusing on providing public-access defibrillators is a key driver for the growth of the global defibrillators market. Additionally, awareness & training programs on application and usage of defibrillators and increase in cases of sudden cardiac arrest (SCA) in younger generation are some of the other drivers propelling the market growth. Nevertheless, technical issues associated with the usage of implantable and automated external defibrillators and high cost of defibrillators treatment are expected to restrain the global market growth.
Based on product, the market is segmented into external defibrillator and implantable cardioverter defibrillator. In 2021, the implantable cardioverter defibrillator segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is attributed to increasing development of technically advanced devices with prolonged longevity and rapid rise in the number of implant procedures being conducted worldwide. External defibrillator segment projected to grow at a profitable CAGR during the forecast period. This is attributed to inventions and improvements in automated ED technology along with the introduction of new products by leading manufactures for increasing their incidence in the market.
Based on end user, the market is segmented into hospitals, clinics, & cardiac centers, public access markets, pre-hospital care settings, home care settings, and alternate care facilities. In 2021, the hospitals, clinics, & cardiac centres segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is attributed to increase in number of cardiac implant processes and the accessibility of compensations worldwide. Public access markets segment projected to grow at a profitable CAGR during the forecast period. This is attributed to the increase in setting up of defibrillators at public places.
In 2021, North America accounted for the highest revenue share in the global market and is expected to maintain its dominance during the forecast period. This is attributed to the presence of key players in the region, growth in initiatives from government to improve access of defibrillators by public, increase in cases of cardiovascular diseases, and accessibility of technological advanced products in the region. Asia Pacific market is projected to exhibit the fastest CAGR over the forecast period owing to the less stringent regulations resulting in major manufacturers willing to expand their geographical presence, growing government and corporate investment in healthcare sector, increasing travel tourism in the developing economies, and rise in number of individuals suffering from sudden cardiac arrests in various countries, are the major factors in this region. Company Insights
Some of the key players in the defibrillators market are BIOTRONIK (Germany); Medtronic (Ireland); Koninklijke Philips N.V. (Netherlands); St. Jude Medical (U.S.); ZOLL Medical Corporation (U.S.); Nihon Kohden (Japan); Mediana (South Korea); Boston Scientific (U.S.); MicroPort (China); CU Medical Systems (South Korea); Mindray Medical (China); Physio-Control (U.S.); Laerdal (Norway); BPL Medical Technologies (India); and SCHILLER AG (Switzerland). The leading players operating in the defibrillators industry are adopting various strategies including R&D investments, adaption of advanced techniques, new technology launches, mergers & acquisitions, and regional expansions to capture a maximum revenue share.This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2021 to 2029. The defibrillators market report is categorized into the following segments and subsegments:
By Product
Based on product, the market is segmented into external defibrillator and implantable cardioverter defibrillator. In 2021, the implantable cardioverter defibrillator segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is attributed to increasing development of technically advanced devices with prolonged longevity and rapid rise in the number of implant procedures being conducted worldwide. External defibrillator segment projected to grow at a profitable CAGR during the forecast period. This is attributed to inventions and improvements in automated ED technology along with the introduction of new products by leading manufactures for increasing their incidence in the market.
By End User
Based on end user, the market is segmented into hospitals, clinics, & cardiac centers, public access markets, pre-hospital care settings, home care settings, and alternate care facilities. In 2021, the hospitals, clinics, & cardiac centres segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is attributed to increase in number of cardiac implant processes and the accessibility of compensations worldwide. Public access markets segment projected to grow at a profitable CAGR during the forecast period. This is attributed to the increase in setting up of defibrillators at public places.
Regional Insights
In 2021, North America accounted for the highest revenue share in the global market and is expected to maintain its dominance during the forecast period. This is attributed to the presence of key players in the region, growth in initiatives from government to improve access of defibrillators by public, increase in cases of cardiovascular diseases, and accessibility of technological advanced products in the region. Asia Pacific market is projected to exhibit the fastest CAGR over the forecast period owing to the less stringent regulations resulting in major manufacturers willing to expand their geographical presence, growing government and corporate investment in healthcare sector, increasing travel tourism in the developing economies, and rise in number of individuals suffering from sudden cardiac arrests in various countries, are the major factors in this region. Company Insights
Some of the key players in the defibrillators market are BIOTRONIK (Germany); Medtronic (Ireland); Koninklijke Philips N.V. (Netherlands); St. Jude Medical (U.S.); ZOLL Medical Corporation (U.S.); Nihon Kohden (Japan); Mediana (South Korea); Boston Scientific (U.S.); MicroPort (China); CU Medical Systems (South Korea); Mindray Medical (China); Physio-Control (U.S.); Laerdal (Norway); BPL Medical Technologies (India); and SCHILLER AG (Switzerland). The leading players operating in the defibrillators industry are adopting various strategies including R&D investments, adaption of advanced techniques, new technology launches, mergers & acquisitions, and regional expansions to capture a maximum revenue share.This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2021 to 2029. The defibrillators market report is categorized into the following segments and subsegments:
Defibrillators Market, By Product (Revenue, USD Billion, 2021 - 2029)
External Defibrillator
- Manual ED
- Automated ED
- Wearable Cardioverter Defibrillators
Implantable Cardioverter Defibrillator
- S-ICD
- T-ICD
- Single Chamber
- Dual Chamber
- CRT-D
Defibrillators Market, By End User (Revenue, USD Billion, 2021 - 2029)
- Hospitals, Clinics, and Cardiac Centers
- Public Access Markets
- Pre-hospital Care Settings
- Home Care Settings
- Alternate Care Facilities
Defibrillators Market, By Region (Revenue, USD Billion, 2021 - 2029)
North America
- U.S.
- Canada
Europe
- Germany
- France
- UK
- Spain
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
Middle East & Africa
- South Africa
- Saudi Arabia
- Rest of MEA
Table of Contents
1. Research Methodology
3. Executive Summary
4. Market Dynamics
5. Market Environment Analysis
6. COVID-19 Impact Analysis: Defibrillator Market
7. Market Analysis by Type
8. Market Analysis by Patients Type
9. Market Analysis by End User
10. Regional Market Analysis
11. North America Defibrillator Market
12. Europe Defibrillator Market
13. Asia Pacific Defibrillator Market
14. Latin America Defibrillator Market
15. MEA Defibrillator Market
16. Competitor Analysis
17. Company Profiles
Companies Mentioned
A selection of companies mentioned in this report includes:
- BIOTRONIK (Germany)
- Medtronic (Ireland)
- Koninklijke Philips N.V. (Netherlands)
- St. Jude Medical (U.S.)
- ZOLL Medical Corporation (U.S.)
- Nihon Kohden (Japan)
- Mediana (South Korea)
- Boston Scientific (U.S.)
- MicroPort (China)
- CU Medical Systems (South Korea)
- Mindray Medical (China)
- Physio-Control (U.S.)
- Laerdal (Norway)
- BPL Medical Technologies (India)
- SCHILLER AG (Switzerland
